Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma
journal contribution
posted on 2022-10-31, 01:27 authored by P Campbell, A Friebe, P Foulstone, A Grigg, J Hempton, A BajelImpact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma
History
Journal
Leukemia and LymphomaVolume
53Pagination
1415-1416Location
United StatesPublisher DOI
ISSN
1042-8194eISSN
1029-2403Language
enPublication classification
CN.1 Other journal articleIssue
7Publisher
Informa UK LimitedUsage metrics
Keywords
AdultBusulfanDrug Administration ScheduleFemaleFibroblast Growth Factor 7Gastric MucosaHodgkin DiseaseHumansIntestinal MucosaLymphoma, Non-HodgkinMaleMelphalanMiddle AgedMucositisRetrospective StudiesStem Cell TransplantationTransplantation ConditioningTransplantation, AutologousTreatment OutcomeYoung Adult
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC